Cutaneous diseases in Latinos

Dermatologic Clinics

Volumn 21, Issue 4, 2003, Pages 689-697

  Sanchez, Miguel R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMMONIUM NITRATE; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASCOMYCIN; AZELAIC ACID; BENZOYL PEROXIDE; CAPSAICIN; CLOBETASOL; CLOFAZIMINE; COBALT; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOSPORIN; GLYCOLIC ACID; HEAVY METAL; HYDROQUINONE; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; PESTICIDE; PSORALEN; RETINOIC ACID; RETINOID; SALICYLIC ACID; TACROLIMUS; TETRACYCLINE; THALIDOMIDE; TRICHLOROACETIC ACID; UNINDEXED DRUG;

ACNE; ACTINIC PRURIGO; AGING; ALOPECIA; ASHY DERMATOSIS; BODY POSTURE; CALLUS; CANCER SURVIVAL; CHLOASMA; CONDYLOMA; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; ECZEMA; ERYTHEMATOSQUAMOUS SKIN DISEASE; ETHNIC GROUP; FIBROMA; HISPANIC; HUMAN; HYPERPIGMENTATION; KNEE; OCULAR ALBINISM; ONYCHOMYCOSIS; PRIORITY JOURNAL; PROGNOSIS; PRURIGO; PSORIASIS; RELIGION; REVIEW; SEBORRHEIC DERMATITIS; SKIN CANCER; SKIN DISEASE; TINEA;

EID: 0346364883     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(03)00087-1     Document Type: Review

References (53)

1. Halder RM, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983;32:388-90.
2. Fitzpatrick SB, Fujii C, Shragg GP, et al. Do health care needs of indigent Mexican-American, black, and white adolescents differ? J Adolesc Health Care 1990;11:128-32.
3. Freyre EA, Rebaza RM, Sami DA, Lozada CP. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health Care 1998;22:480-4.
4. Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002;45(2 suppl):S98-106.
5. Taylor SC. Cosmetic problems in skin of color. Skin Pharmacol Appl Skin Physiol 1999;12:139-43.
6. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999;25:18-22.
7. Ruiz-Esparza J, Barba Gomez JM, Gomez de la Torre OL, et al. UltraPulse laser skin resurfacing in Hispanic patients: a prospective study of 36 individuals. Dermatol Surg 1998;24:59-62.
8. Christiansen SC, Martin SB, Schleicher NC, et al. Exposure and sensitization to environmental allergen of predominantly Hispanic children with asthma in San Diego's inner city. J Allergy Clin Immunol 1996;98:288-94.
9. Mandry Pagan R, Sanchez JL. Mandibular melasma. P R Health Sci J 2000;19:231-4.
10. Guevara IL, Pandya AG. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid. Int J Dermatol 2001;40:212-5.
11. Cotellessa C, Peris K, Onorati MT, et al. The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg 1999;25:450-4.
12. 2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg 1999;25:494-7.
13. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin 2000;18:91-8.
14. Penagos H, Jimenez V, Fallas V, et al. Chlorothalonil, a possible cause of erythema dyschromicum perstans (ashy dermatitis). Contact Dermatitis 1996;35:214-8.
15. Jang KA, Choi JH, Sung KS, et al. Idiopathic eruptive macular pigmentation: report of 10 cases. J Am Acad Dermatol 2001;44(2 suppl):351-3.
16. Mizukawa Y, Shiohara T. Fixed drug eruption presenting as erythema dyschromicum perstans: a flare without taking any medications. Dermatology 1998;197:383-5.
17. Lines III RR, Hansen RC. A hyperpigmented, rippled eruption in a Hispanic woman: macular amyloidosis. Arch Dermatol 1997;133:383-6.
18. Baranda L, Torres-Alvarez B, Cortes-Franco R, et al. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis): the effect of clofazimine therapy. Arch Dermatol 1997;133:325-9.
19. Piquero-Martin J, Perez-Alfonzo R, Abrusci V, et al. Clinical trial with clofazimine for treating erythema dyschromicum perstans. Evaluation of cell-mediated immunity. Int J Dermatol 1989;28:198-200.
20. Osswald SS, Proffer LH, Sartori CR. Erythema dyschromicum perstans: a case report and review. Cutis 2001; 68:25-8.
21. Lane PR, Hogan DJ, Martel MJ, et al. Actinic prurigo: clinical features and prognosis. J Am Acad Dermatol 1992;26(5 pt 1):683-92.
22. Grabczynska SA, McGregor JM, Kondeatis E, et al. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/ DRB1*0407. Br J Dermatol 1999;140:232-6.
23. Magana M, Mendez Y, Rodriguez A, Mascott M. The conjunctivitis of solar (actinic) prurigo. Pediatr Dermatol 2000;17:432-5.
24. Rodriguez-Cuevas S, Lopez-Chavira A, Zepeda del Rio G, et al. Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma. Arch Med Res 1998;29:155-8.
25. Hojyo-Tomoka T, Granados J, Vargas-Alarcon G, et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol 1997;36(6 pt 1):935-7.
26. Lane PR, Murphy F, Hogan DJ, et al. Histopathology of actinic prurigo. Am J Dermatopathol 1993;15:326-31.
27. Lane PR, Moreland AA, Hogan DJ. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate: a preliminary report. Arch Dermatol 1990;126:1211-3.
28. Arrese JE, Dominguez-Soto L, Hojyo-Tomoka MT, et al. Effectors of inflammation in actinic prurigo. J Am Acad Dermatol 2001;44:957-61.
29. Torres-Alvarez B, Baranda L, Fuentes C, et al. An immunohistochemical study of UV-induced skin lesions in actinic prurigo: resistance of Langerhans cells to UV light. Eur J Dermatol 1998;8:24-8.
30. Lovell CR, Hawk JL, Calnan CD, Magnus IA. Thalidomide in actinic prurigo. Br J Dermatol 1983;108:467-71.
31. Duran MM, Ordonez CP, Prieto JC, Bernal J. Treatment of actinic prurigo in Chimila Indians. Int J Dermatol 1996;35:413-6.
32. Las DY, Youn JI, Park MH, Chung JH. Actinic prurigo: limited effect of PUVA [letter]. Br J Dermatol 1997; 136:972-3.
33. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995;132:956-63.
34. McCoombes JA, Hirst LW, Green WR. Use of topical cyclosporin for conjunctival manifestations of actinic prurigo. Am J Ophthalmol 2000;130:830-1.
35. Wildenberg SC, Oetting WS, Almodovar C, et al. A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. Am J Hum Genet 1995;57:755-65.
36. Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch Dermatol 1999;135:774-80.
37. Burnett JW. Capsicum pepper dermatitis. Cutis 1989; 534.
38. Jones LA, Tandberg D, Troutman WG. Household treatment for "chile burns" of the hands. Clin Toxicol 1987;25:483-91.
39. Stoner JG. Miscellaneous dermatitis-inducing plants. Clin Dermatol 1986;4:94-101.
40. Mishriki YY. Skin commotion from repetitive devotion: prayer callus. Postgrad Med 1999;105:153-4.
41. Vollum DI, Azadeh B. Prayer nodules. Clin Exp Dermatol 1979;4:39-47.
42. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001;45:528-36.
43. Shaw M, Sanguinetti O, de Kaminsky AR, Kaminsky CA. Basal and spinous cell epitheliomas. Med Cutan Ibero Lat Am 1975;3:471-5.
44. Hoy WE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 1996;77:2489-95.
45. Bigler C, Feldman J, Hall E, Padilla RS. Pigmented basal cell carcinoma in Hispanics. J Am Acad Dermatol 1996;34(5 pt 1):751-2.
46. Maafs E, De la Barreda F, Delgado R, et al. Basal cell carcinoma of trunk and extremities. Int J Dermatol 1997;36:622-8.
47. Grinspan D, Biagini R. Chronic endemic regional hydroarsenicism: the manifestations of arsenic poisoning caused by drinking water. Med Cutan Ibero Lat Am 1985;13:85-109.
48. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control 1997;8:246-52.
49. Black WC, Goldhahn Jr RT, Wiggins C. Melanoma within a southwestern Hispanic population. Arch Dermatol 1987;123:1331-4.
50. Feun LG, Raub Jr WA, Duncan RC, et al. Melanoma in a southeastern Hispanic population. Cancer Detect Prev 1994;18:145-52.
51. Hall HI, Jones SE, Saraiya M. Prevalence and correlates of sunscreen use among US high school students. J Sch Health 2001;71:453-7.
52. Hoegh HJ, Davis BD, Manthe AF. Sun avoidance practices among non-Hispanic white Californians. Health Educ Behav 1999;26:360-8.
53. Friedman LC, Bruce S, Weinberg AD, et al. Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J Cancer Educ 1994;9:105-10.